AIM-PA.TO
Aimia Inc.$22.00
Jun 02, 2026
Market cap
$1.38M
52w range
—
P / E
—
EPS
—
Volume
—
Revenue · FY
—
Explain this page
Arphra AIPlain-English read on Aimia Inc.’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
—
— vs spot
Recommendation
n/a
0 of 0 methods
Method spread
0bull0bear
±5% threshold
Candlestick · 1Y
Open in chart workstation →AIM-PA.TO
22.00+3.04%H 22.83L 21.35MA50 21.93MA200 —Avg vol 280
Insider · 30d
History →Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Sector & industry today
LiveSectors
- Financial Services+1.26%
- Utilities+0.83%
- Communication Services+0.46%
- Energy+0.45%
- Technology+0.34%
- Consumer Defensive-0.21%
- Industrials-0.32%
- Healthcare-0.39%
- Real Estate-0.67%
- Consumer Cyclical-0.94%
- Basic Materials-1.06%
Top industries (issuer's industry highlighted)
- Biotechnology-0.28%
- Department Stores-6.26%
- Broadcasting-4.30%
- Education & Training Services-3.71%
- Medical - Equipment & Services+3.71%
- Solar-3.63%
- Electronic Gaming & Multimedia+3.56%
- Steel-3.33%
- Real Estate - Development-3.31%
- Trucking-3.16%
- Copper-3.02%
- Coal-2.91%
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_items- AIM ImmunoTech Regains NYSE American Compliance, Company Resolves Stockholder Equity Deficiencyglobenewswire.com·Jun 15, 2026
- AIM ImmunoTech Regains NYSE American Compliance, Company Resolves Stockholder Equity Deficiencyglobenewswire.com·Jun 15, 2026
- Union Jack Oil reveals takeover approach by Reabold Resourcesproactiveinvestors.co.uk·Jun 15, 2026
- Poolbeg Pharma shows clinical progress with latest updatesproactiveinvestors.co.uk·Jun 11, 2026
- PAF raises £800,000 to advance Zimbabwe lithium projectproactiveinvestors.co.uk·Jun 11, 2026
- Coastal Africa joins AIM with BP topping up £27m coffersproactiveinvestors.co.uk·Jun 10, 2026
- AIM ImmunoTech Announces $2.65 Million Financing Priced At-Market under NYSE American Rulesglobenewswire.com·Jun 09, 2026
- AIM ImmunoTech Announces $2.65 Million Financing Priced At-Market under NYSE American Rulesglobenewswire.com·Jun 09, 2026
Peers
No peer list available for AIM-PA.TO.
Total assets
—
Total debt
—
Cash & equiv
—
Operating CF
—
Free cash flow
—
Buybacks
—
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|